Literature DB >> 17982698

Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation.

Christine Riebe1, Ralph Pries, Andrea Kemkers, Barbara Wollenberg.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the most frequently diagnosed cancers. It is believed that tumor production of various immune suppressive mediators contributes to massively impaired immune functions, but the underlying signal transduction pathways are mostly unknown. Phosphorylation levels of MAP (mitogen-activated protein) kinase p38 were analyzed in permanent cell lines as well as in solid tumor tissue of HNSCC using flow cytometry and SDS-PAGE. Cytokine secretion was determined using the Cytometric Bead Array Flex Set system. MAP kinase p38 was shown to be activated in HNSCC by phorbol 12-myristate 13-acetate. Activation of p38 led to decreased cell proliferation and increased secretion of cytokines IL-6 and IL-8 in HNSCC. Our data provide novel insights into the origin of the HNSCC microenvironment. A better understanding of these molecular mechanisms in HNSCC is essential for novel drug development and improvement of the clinical perspective of this tumor type.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982698

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.

Authors:  Rajat Banerjee; Elizabeth A Van Tubergen; Christina S Scanlon; Robert Vander Broek; Joel P Lints; Min Liu; Nickole Russo; Ronald C Inglehart; Yugang Wang; Peter J Polverini; Keith L Kirkwood; Nisha J D'Silva
Journal:  Mol Cancer Ther       Date:  2014-02-25       Impact factor: 6.261

2.  Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.

Authors:  Elizabeth Van Tubergen; Robert Vander Broek; Julia Lee; Gregory Wolf; Thomas Carey; Carol Bradford; Mark Prince; Keith L Kirkwood; Nisha J D'Silva
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

3.  p38 Expression and Modulation of STAT3 Signaling in Oral Cancer.

Authors:  I Gkouveris; N Nikitakis; A Sklavounou
Journal:  Pathol Oncol Res       Date:  2018-03-21       Impact factor: 3.201

4.  The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.

Authors:  Kwame Osei-Sarfo; Xiao-Han Tang; Alison M Urvalek; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Carcinogenesis       Date:  2013-06-19       Impact factor: 4.944

5.  Cytokine signatures of human whole blood for monitoring immunosuppression.

Authors:  Yi He; Yuwei Luo; Xiaobin Lao; Liping Tan; Erwei Sun
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

6.  The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.

Authors:  Kamaldeep Gill; Lokesh Nigam; Ratnakar Singh; Suresh Kumar; Naidu Subbarao; Shyam Singh Chauhan; Sharmistha Dey
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

Review 7.  IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.

Authors:  Michal Španko; Karolína Strnadová; Aleš Jan Pavlíček; Pavol Szabo; Ondřej Kodet; Jaroslav Valach; Barbora Dvořánková; Karel Smetana; Lukáš Lacina
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

8.  The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer.

Authors:  Zhibin Jing; Hongbo Xu; Xiaohong Chen; Qi Zhong; Junwei Huang; Yang Zhang; Wei Guo; Zheng Yang; Shuo Ding; Ping Chen; Zhigang Huang
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.